 |
Botulinum toxin type A |
|---|---|
| Trade Name | |
| Orphan Indication | Synkinetic closure of the eyelid associated with VII cranial nerve aberrant regeneration |
| USA Market Approval | USA |
| USA Designation Date | 1992-09-15 00:00:00 |
| Sponsor | Botulinum Toxin Research Associates, Inc.;1261 Furnace Brook Parkway;Quincy, Massachusetts, 02169 |
